阿尔茨海默病治疗费用高 礼来呼吁将靶向病因创新药纳入医保

第一财经
Yesterday

在今年的两会上,人口老龄化问题被提上日程,政府正在着手应对快速老龄化对经济社会带来的挑战,并有望出台更多措施,增进老年人的福祉。这也让在中国积极布局健康产业的跨国医疗企业看到巨大的市场潜力。  近日,礼来中国总裁兼总经理德赫兰(Huzur Devletsah)在接受第一财经记者独家专访时呼吁,尽快将用于阿尔茨海默病疾病早期、靶向病因、可显著减缓疾病进程的创新药物纳入医保,提升患者的可及性和可负担性...

Source Link

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10